About SDI Labs Inc.
SDI Labs was founded in 1987 by two molecular cytogeneticists from UCLA. In 2014, the company received significant financial backing and added highly skilled IT leaders. As a result, SDI Labs expanded their focus to molecular diagnostics of infectious diseases, women’s health, and autoimmune and mental health diagnostics. By adding deep software development expertise, SDI Labs has been able to leverage data science and automation to develop data-driven pathogen detection testing for various infectious diseases.
Science, Software, Scale & Speed for Coronavirus testing.
With its clinical expertise and data-driven approach to testing, SDI Labs is uniquely positioned to address the testing needs for Coronavirus. The SDI proprietary testing system can provide isolation and specific detection of SARS COV-2 (coronavirus) testing with a quick 24-to-48-hour turnaround time. SDI Labs renowned scientific team is helmed by Chief Medical Director, Dr. Sajo Beqaj, and includes clinical lab scientists, certified medical technicians, and state-of-the-art lab automation tools.
SDI Lab is a high complexity, molecular diagnostics, CLIA certified and CAP accredited facility. Our clients include Medicare and Medicaid programs and commercial Insurance groups such has Anthem Blue, Humana, Blue Cross Blue Shield of California, and many other national health plans. SDI is credentialed with 20+ IPAs (Independent Physicians Association) in California.